These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36457968)

  • 21. Overcoming Obstacles in Lipid-lowering Therapy in Patients with HIV - A Systematic Review of Current Evidence.
    Dekkers CC; Westerink J; Hoepelman AIM; Arends JE
    AIDS Rev; 2018; 20(4):205-219. PubMed ID: 30548018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea.
    Han KT; Kim S
    BMC Cancer; 2022 Feb; 22(1):156. PubMed ID: 35135497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Umbrella Review on Non-Statin Lipid-Lowering Therapy.
    Beshir SA; Hussain N; Elnor AA; Said ASA
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):437-452. PubMed ID: 33836639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC
    Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast China: Subgroup analysis of the dyslipidemia international study of China (DYSIS-China).
    Zheng W; Zhang YJ; Bu XT; Guo XZ; Hu DY; Li ZQ; Sun J
    Medicine (Baltimore); 2017 Nov; 96(46):e8555. PubMed ID: 29145263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized lipid-lowering therapy to further reduce residual cardiovascular risk.
    Weingärtner O; Lütjohann D; Plösch T; Elsässer A
    J Steroid Biochem Mol Biol; 2017 May; 169():198-201. PubMed ID: 27215141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus.
    Kosmas CE; Silverio D; Sourlas A; Garcia F; Montan PD; Guzman E
    Drugs Context; 2018; 7():212562. PubMed ID: 30515229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
    Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study.
    Tsai MH; Chen M; Huang YC; Liou HH; Fang YW
    Front Pharmacol; 2021; 12():804000. PubMed ID: 35153758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation.
    Rymer JA; Mues KE; Monda KL; Bratton EW; Wirtz HS; Okerson T; Overman RA; Brookhart MA; Muntner P; Wang TY
    J Am Heart Assoc; 2020 May; 9(9):e014347. PubMed ID: 32326795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis.
    Hirakawa Y; Arima H; Rodgers A; Woodward M; Chalmers J
    J Hypertens; 2017 May; 35(5):905-913. PubMed ID: 28060187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension.
    van de Veerdonk MC; Huis In T Veld AE; Marcus JT; Westerhof N; Heymans MW; Bogaard HJ; Vonk-Noordegraaf A
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28663315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach.
    Grant JK; Snow S; Kelsey M; Rymer J; Schaffer AE; Patel MR; McGarrah RW; Pagidipati NJ; Shah NP
    Curr Cardiol Rep; 2022 Oct; 24(10):1373-1385. PubMed ID: 35904667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender disparities in lipid-lowering therapy among veterans with diabetes.
    Vimalananda VG; Miller DR; Palnati M; Christiansen CL; Fincke BG
    Womens Health Issues; 2011; 21(4 Suppl):S176-81. PubMed ID: 21724138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
    Simonyi G
    Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and control of BP and lipids in patients with hypertension and additional risk factors.
    Welch V; Tang SS
    Am J Cardiovasc Drugs; 2007; 7(5):381-9. PubMed ID: 17953476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipid lowering therapy: new pathophysiologic aspects and clinical implications].
    Nordmann A; Martina B; Keller U; Battegay E
    Schweiz Med Wochenschr; 1998 Apr; 128(17):665-70. PubMed ID: 9622839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage - A Meta-Analysis.
    Judge C; Ruttledge S; Costello M; Murphy R; Loughlin E; Alvarez-Iglesias A; Ferguson J; Gorey S; Nolan A; Canavan M; O'Halloran M; O'Donnell MJ
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1703-1709. PubMed ID: 30878368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.